The Clinical Approach and Treatment of Benign and Malignant Parotid Masses

PDF

DOI: https://doi.org/10.12816/0028227

Marwan G Saied

Abstract

Background: Parotid gland tumors account for 80% of all salivary gland neoplasms, 20% of these are malignant, but in daily clinical practice most parotid masses are operated on before obtaining the final histological diagnosis. This clinical setting further complicates the critical point of parotid surgery, which is the management of the facial nerve. Materials and methods: 45 patients underwent parotidectomy for benign and malignant neoplasms. A complete history is collected from the patients with the duration and the site of the tumor, the facial nerve examined and its associations, a medical consultation done for opinion and management. Clinical examination with facial nerve was mandatory to avoid any mistakes that may occur. The most significant single parameter in this series of malignancies regarding disease specific survival was the clinical involvement of the facial nerve. Also for this reason, as there is no evidence that the facial nerve sacrifice improves prognosis, when it is not clinically involved, every attempt is made to dissect and preserve it. A treatment plan was contemplated regarding nerve preservation for malignancy or with nerve sacrifice.
Result: This study showed that females (62%) are more affected than males (38%),tumors occur at left parotid gland (65%) more than right parotid gland (35%), a malignancy affected the left parotid gland more than the right one and a malignancy affected females more than males. Pleomorphic adenomas are the most frequent benign tumors while the adenocarcinoma most frequent malignant tumors.
Conclusion: The most complicated situation concerning nerve preservation may be the recurrence of a benign tumor, in particular pleomorphic adenoma, which, in our series, has a higher incidence (62.5%) of permanent facial dysfunction, than surgery with nerve preservation for malignancy (37.5%) and to resects the nerve when is clinically involved and when is totally embedded in a clearly malignant neoplasm with attempt to preserve it in all other.

Downloads

Download data is not yet available.

How to Cite

Saied MG. The Clinical Approach and Treatment of Benign and Malignant Parotid Masses. J Bagh Coll Dent [Internet]. 2016 Jun. 15 [cited 2024 Nov. 19];28(2):84-91. Available from: https://jbcd.uobaghdad.edu.iq/index.php/jbcd/article/view/1151

Issue

Vol. 28 No. 2 (2016)

Section

Oral and Maxillofacial Surgery and Periodontics

Licenses and Copyright

The following policy applies in The Journal of Baghdad College of Dentistry (JBCD):

# JBCD applies the Creative Commons Attribution (CC BY) license to articles and other works we publish. If you submit your paper for publication by JBCD, you agree to have the CC BY license applied to your work. Under this Open Access license, you as the author agree that anyone can reuse your article in whole or part for any purpose, for free, even for commercial purposes. Anyone may copy, distribute, or reuse the content as long as the author and original source are properly cited. This facilitates freedom in re-use and also ensures that JBCD content can be mined without barriers for the needs of research.

# If your manuscript contains content such as photos, images, figures, tables, audio files, videos, etc., that you or your co-authors do not own, we will require you to provide us with proof that the owner of that content (a) has given you written permission to use it, and (b) has approved of the CC BY license being applied to their content. We provide a form you can use to ask for and obtain permission from the owner. If you do not have owner permission, we will ask you to remove that content and/or replace it with other content that you own or have such permission to use.Don't assume that you can use any content you find on the Internet, or that the content is fair game just because it isn't clear who the owner is or what license applies.

# Many authors assume that if they previously published a paper through another publisher, they own the rights to that content and they can freely use that content in their paper, but thatâ€™s not necessarily the case, it depends on the license that covers the other paper. Some publishers allow free and unrestricted re-use of article content they own, such as under the CC BY license. Other publishers use licenses that allow re-use only if the same license is applied by the person or publisher re-using the content. If the paper was published under a CC BY license or another license that allows free and unrestricted use, you may use the content in your JBCD paper provided that you give proper attribution, as explained above.If the content was published under a more restrictive license, you must ascertain what rights you have under that license. At a minimum, review the license to make sure you can use the content. Contact that JBCD if you have any questions about the license. If the license does not permit you to use the content in a paper that will be covered by an unrestricted license, you must obtain written permission from the publisher to use the content in your JBCD paper. Please do not include any content in your JBCD paper which you do not have rights to use, and always give proper attribution.

# If any relevant accompanying data is submitted to repositories with stated licensing policies, the policies should not be more restrictive than CC BY.

# JBCD reserves the right to remove any photos, captures, images, figures, tables, illustrations, audio and video files, and the like, from any paper, whether before or after publication, if we have reason to believe that the content was included in your paper without permission from the owner of the content.